Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04130152
Title Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors SOLTI Breast Cancer Research Group
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole + Palbociclib

Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.